Robeco Institutional Asset Management B.V. Trims Stock Holdings in Ventas, Inc. $VTR

Robeco Institutional Asset Management B.V. cut its holdings in shares of Ventas, Inc. (NYSE:VTR) by 19.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 119,649 shares of the real estate investment trust’s stock after selling 28,664 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Ventas were worth $8,374,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in VTR. True Wealth Design LLC boosted its stake in shares of Ventas by 1,557.7% during the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after buying an additional 405 shares during the last quarter. Ameritas Advisory Services LLC acquired a new stake in Ventas in the second quarter valued at $33,000. Golden State Wealth Management LLC raised its holdings in Ventas by 52.7% in the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 185 shares in the last quarter. Elevation Point Wealth Partners LLC bought a new position in Ventas during the 2nd quarter valued at $35,000. Finally, IFP Advisors Inc grew its holdings in Ventas by 61.3% during the 2nd quarter. IFP Advisors Inc now owns 974 shares of the real estate investment trust’s stock worth $62,000 after acquiring an additional 370 shares in the last quarter. 94.18% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.26, for a total value of $797,477.72. Following the sale, the chief executive officer owned 1,145,695 shares in the company, valued at approximately $88,516,395.70. This trade represents a 0.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the sale, the chief financial officer directly owned 138,434 shares in the company, valued at approximately $10,694,026.50. This trade represents a 17.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 713,520 shares of company stock valued at $52,788,577 in the last quarter. Company insiders own 0.80% of the company’s stock.

Ventas Stock Down 0.2%

NYSE:VTR opened at $74.90 on Friday. The company has a current ratio of 0.32, a quick ratio of 0.32 and a debt-to-equity ratio of 1.01. The stock has a 50 day moving average of $78.25 and a 200-day moving average of $71.31. The firm has a market capitalization of $35.18 billion, a PE ratio of 144.05, a price-to-earnings-growth ratio of 1.86 and a beta of 0.78. Ventas, Inc. has a 52 week low of $56.97 and a 52 week high of $81.89.

Ventas (NYSE:VTR) last released its quarterly earnings data on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.01. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.44 billion. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.80 EPS. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be given a dividend of $0.48 per share. The ex-dividend date is Wednesday, December 31st. This represents a $1.92 annualized dividend and a dividend yield of 2.6%. Ventas’s dividend payout ratio is currently 369.23%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Citigroup upped their target price on shares of Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research note on Tuesday, November 11th. Wells Fargo & Company boosted their price objective on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, November 25th. Cantor Fitzgerald restated an “overweight” rating and set a $93.00 price objective on shares of Ventas in a research note on Monday. The Goldman Sachs Group started coverage on Ventas in a report on Friday. They set a “buy” rating and a $94.00 target price on the stock. Finally, Scotiabank boosted their price target on Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a report on Thursday, November 13th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, Ventas currently has an average rating of “Moderate Buy” and a consensus target price of $80.65.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.